Target intelligence / Profile preview

Glycoside hydrolase

Molecular classification
Enzyme, Hydrolase, Carbohydrate-active enzyme
01

Overview

Glycoside hydrolase is a canonical name for a large and diverse class of enzymes that catalyze the hydrolysis (breakdown) of glycosidic bonds within carbohydrates or between a carbohydrate and a non-carbohydrate moiety[1][2][5][7]. These enzymes, which also include the terms glycosidase and glycosyl hydrolase, are present in all domains of life and have critical roles in carbohydrate digestion, nutrient uptake, processing of glycoproteins and glycolipids, lysosomal function, and biomass degradation[1][4][5][7]. Many glycoside hydrolases are clinically important: defects cause lysosomal storage disorders (e.g., Gaucher disease), and specific enzymes (such as glucosidase, galactosidase, and neuraminidase) are targeted for disease treatment[3][4]. Glycoside hydrolases are classified by sequence homology and substrate specificity into over 160 families (as curated by the CAZy database), and they utilize characteristic catalytic mechanisms (retaining or inverting the anomeric configuration) to cleave substrates[2][3][5][7]. This class of enzymes is also a major focus for drug and biotechnology development due to its central role in human health, disease, and industrial applications[2][3][7].

Other names
GlycosidaseGlycosyl hydrolaseGH (e.g., in family names such as "GH116")Glycoside hydrolases
02

Mechanism of action

Competitive inhibition of specific glycosidases (e.g., substrate mimetics inhibiting GBA1, GBA2); Enzyme replacement therapy (supplying deficient or defective enzyme); Pharmacological chaperoning (stabilizing misfolded enzyme)

03

Biological functions

Carbohydrate metabolismBiomass degradationNutrient acquisitionGlycoprotein processingCellular digestionLysosomal function
04

Disease associations

Lysosomal storage disorders (e.g., Gaucher disease, Niemann-Pick disease type C)Metabolic diseases (e.g., diabetes)Neurological diseases (e.g., autosomal-recessive cerebellar ataxia, hereditary spastic paraplegia)Cancer (implicated)Infection (pathogen virulence factors)
05

Safety considerations

Off-target inhibition affecting healthy carbohydrate metabolismImmune reactions to enzyme replacement therapiesPossible gastrointestinal side effects (with oral inhibitors)
06

Interacting drugs

Miglustat

3 more in the full profile.

07

Biomarkers

Accumulation of glycosphingolipids (e.g., glucosylceramide for Gaucher disease)Enzyme activity assays for β-glucosidase, β-galactosidase, etc.

Beyond the preview

Go deeper on Glycoside hydrolase.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Glycoside hydrolase.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call